46
K. G. McMillan et al. / Carbohydrate Research 341 (2006) 41–48
18
as white crystals (104 mg, 74%); mp 134–137 ꢀC; ½aꢂD
organic layer was dried (MgSO4) and concentrated in
vacuo. The resulting solid was recrystallised from
CHCl3/Et2O to afford the title compound as fine white
crystals (478 mg, 46%); mp partially 112–114 ꢀC, totally
146–147 ꢀC (lit.7 partially 112–114 ꢀC, totally 146–
1
ꢀ41.7 (c 0.48, CHCl3). H NMR (250 MHz, CDCl3): d
1.95, 1.98, 1.99 (3 · s, 9H, COCH3), 3.36 (dd, 1H, H-
5a0), 4.20 (dd, 1H, H-5e0), 4.25 (d, 1H, H-10), 5.00
(ddd, 1H, H-40), 5.16 (t, 1H, H-20), 5.22 (t, 1H, H-30);
J(x–y)/Hz 10–20 9.3, 20-30 9.3, 30–40 9.1, 40–50a 10.7, 40–
50e 5.5, 50a–50e 11.4. 13C NMR (63 MHz, CDCl3): d
20.3, 20.5 (3 · COCH3), 66.8 (C-5), 68.1, 69.1 72.0 (C-
20, C-30, C-40), 74.5 (C-10), 155.4 (C-5), 169.3, 169.5,
169.9 (3 · COCH3), 172.2 (C-2). HRFABMS: (m/z):
[M+H]+ calcd for C12H16NO9S, 362.0547; found,
362.0546.
25
147 ꢀC); ½aꢂD +103.1 (c 0.98, CHCl3). 1H NMR
(250 MHz, CDCl3): d 1.81, 1.85, 1.88, 1.93 (4 · s, 9H,
COCH3), 3.57–3.59 (m, 1H, H-5), 3.69 (d, 1H, H-1),
4.00 (m, 2H, H-6a, H-6b), 5.10 (t, 1H, H-2), 5.28 (t,
1H, H-4), 5.42 (t, 1H, H-3), 5.49 (br s, 1H, CONH2);
J(x–y)/Hz 1–2 9.6, 2–3 9.7, 3–4 9.7, 4–5 10.3, 5–5a 7.0,
5–6b 2.2, 6a–b 13.0. 13C NMR (63 MHz, CDCl3): d
20.2, 20.4, 20.5 (4 · COCH3), 61.8 (C-7), 66.4, 68.1
73.6, 75.0. 75.9 (C-1, C-2, C-3, C-4, C-5), 169.1, 169.8,
170.4, 170.5 (4 · COCH3, CONH2). HRFABMS: (m/
z): [M+H]+ calcd for C15H22NO10, 376.1244; found,
376.1244.
4.4. 5-(2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl)-1,3,4-
oxathiazol-2-one (13)
4.4.1. 2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl cyanide
(15). Phosphorus trichloride (0.4 mL, 4.58 mmol) was
added to an ice-cold solution of nitromethyl-glucose
derivative 14 (1.50 g, 3.84 mmol) in pyridine under
nitrogen; the reaction mixture was allowed to warm to
room temperature and left stirring for 72 h. The result-
ing dark-brown mixture was quenched with ice-cold aq
HCl (1 M, ca. 150 mL) and left stirring for 1 h then
extracted with chloroform (3 · 150 mL). The organic
extracts were combined, washed with satd aq NaHCO3
(100 mL), H2O (50 mL) and satd aq NaCl (50 mL).
The organic layers were then dried (MgSO4) and the sol-
vent removed in vacuo to give an orange-brown oil. This
was dissolved in CH2Cl2 (ca. 100 mL), passed through a
silica pad and concentrated in vacuo to give the title
compound as a white solid (812 mg, 59%); mp 110–
111 ꢀC (lit.23 114–115 ꢀC); Rf 0.33 (petroleum ether/
ethyl acetate, 1:1); 1H NMR (250 MHz, CDCl3): d
2.03, 2.04, 2.11 (4 · s, 12H, COCH3), 3.73 (m, 1H, 5-
H), 4.20 (m, 2H, 6a-H, 6b-H), 4.33 (d, 1H, 1-H), 5.07–
5.22 (m, 2H, 2-H, 4-H), 5.32 (t, 1H, 3-H); J(x–y)/Hz
1–2 10.1, 2–3 9.8, 3–4 9.8, 4–5 9.4, 5–6a 4.8, 5–6b 2.3,
6a–e 12.7; 13C NMR (63 MHz, CDCl3): d 20.3
(4 · COCH3), 61.3 (C-6), 66.3, 67.1, 68.8, 72.7, 76.7
(C-1. C-2, C-3, C-4, C-5), 114.0 (CN), 168.6, 169.0,
169.9, 170.4 (4 · COCH3); HRFABMS: (m/z):
[M+H]+ calcd for C15H20NO9, 358.1138; found,
358.1137.
4.4.3.
1,3,4-oxathiazol-2-one
5-(2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl)-
(13). Chlorocarbonylsulfenyl
chloride (0.1ml, 1.2 mmol) was added to a solution of
carboxamide 16 (100 mg, 0.27 mmol) in Na-dried tolu-
ene (3 mL), and the mixture heated at reflux for 4 h.
The reaction mixture was concentrated in vacuo, azeo-
troped with toluene and then passed through a silica
pad [cyclohexane/ethyl acetate, 1:1 (50 mL)] and con-
centrated in vacuo to give the title compound as a white
25
solid (88 mg, 75%); mp 112–113 ꢀC; ½aꢂD +1.8 (c 1.64,
CHCl3); Rf 0.43 (petroleum ether/ethyl acetate, 1:1);
1H NMR (250 MHz, CDCl3): d 2.02, 2.03, 2.07, 2.09
(4 · s, 12H, COCH3), 3.70 (m, 1H, 50-H), 4.18 (m, 2H,
60a-H, 6b0-H), 4.48 (d, 1H, 10-H), 5.17 (t, 1H, 20-H),
5.30 (t, 1H, 40-H), 5.52 (t, 1H, 30-H); J(x–y)/Hz 10–20
10.0, 20–30 9.6, 30–40 9.6, 40–50 9.4, 50–60a nd, 50–60b
nd, 60a–60b nd; 13C NMR (63 MHz, CDCl3): d 20.3,
20.4 (4 · COCH3), 61.5 (C-60), 66.3, 67.9, 70.2, 72.8,
73.8 (C-10, C-20, C-30, C-40, C-50), 156.1 (C-5), 168.9,
169.3, 169.7 (4 · COCH3) 170.0 (C-2); HRFABMS:
(m/z): [M+H]+ calcd for C16H20NO11S, 434.0757; found
434.0752.
4.5. 1,2,3,4-Tetra-O-acetyl-a-D-glucuronic acid nitrile
(21)
A solution of 1,2,3,4-tetra-O-acetyl-a-D-glucuronamide
(7) (220 mg, 0.61 mmol) in thionyl chloride (1.0 mL)
was heated at reflux for 72 h, then passed through a sil-
ica pad (eluting with 1:1 cyclohexane/EtOAc, 50 mL)
and concentrated in vacuo to afford the title compound
4.4.2.
amide
2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosylform-
(16). Titanium tetrachloride (0.05 mL,
0.46 mmol) and water (0.06 mL) were added to an ice-
cold solution of 2,3,4,6-tetra-O-acetyl-b-D-glucpyran-
osyl cyanide (1.00 g, 2.80 mmol) in glacial acetic acid
(5 mL) and the mixture stirred at 0 ꢀC for 30 min. The
mixture was allowed to warm to room temperature
and then stirred for 5 days. It was then poured into
ice-water (50 mL) and extracted with CHCl3
(3 · 50 mL). The combined organic layers were washed
with satd aq NaHCO3 (50 mL) and satd aq NaCl. The
25
as a white (155 mg, 74%); mp 212–215 ꢀC; ½aꢂD +83.9 (c
0.62, CHCl3); Rf 0.65 (petroleum ether/ethyl acetate,
1
1:1); H NMR (250 MHz, CDCl3): d 2.28, 2.30, 2.37,
2.47 (4 · s, 12H, COCH3), 4.98 (d, 1H, 5-H), 5.35 (dd,
1H, 2-H), 5.54–5.70 (m, 2H, 3-H, 4-H), 6.62 (d, 1H, 1-
H); J(x–y)/Hz 1–2 3.7, 2–3 9.5, 3–4 nd, 4–5 10.0; 13C
NMR (63 MHz, CDCl3): d 20.2, 20.6 (4 · COCH3),